ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0363

Assessing Whole Health Needs in Systemic Lupus Erythematosus

Amanda Eudy1, Megan Clowse2, Dana Burshell3, Connor Drake3, Tamara Somers4, David Pisetsky5, Rebecca Sadun6, Ralph Snyderman7, Kai Sun6, Lisa Criscione-Schreiber3, Mithu Maheswaranathan3, Nathaniel Harris5, Jayanth Doss8 and Jennifer Rogers3, 1Duke University, Raleigh, NC, 2Duke University, Chapel Hill, NC, 3Duke University School of Medicine, Durham, 4Duke University School of Medicine, Durham, NC, 5Duke University Medical Center, Durham, NC, 6Duke University, Durham, NC, 7Duke Center for Personalized Health Care, Durham, NC, 8Division of Rheumatology and Immunology, Duke University Department of Medicine, Durham, NC

Meeting: ACR Convergence 2025

Keywords: Patient reported outcomes, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0357–0386) Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Care models that take a ‘Whole Health’ perspective by emphasizing personalized care focused on the individual’s values, needs, and goals, rather than solely on medical conditions are sorely needed for patients with SLE. Enhancing self-care can significantly improve overall well-being but is often missing from SLE management. This study aims to identify the greatest self-care needs for individuals with SLE using a modified Whole Health Self-Assessment survey, focusing on differences by subgroups of Type 2 SLE activity (Intermittent and Persistent).

Methods: Patients with SLE enrolled in a lupus registry completed the Polysymptomatic Distress Score (PSD), FACIT Fatigue scale, PROMIS measures, and a modified Whole Health Self-Assessment, rating their health on a visual analog scale across 10 domains (Table 1). Participants also selected their three most important areas for self-care. Rheumatologists scored the SLEDAI and Type 1 & 2 physician’s global assessments (PGA). Spearman’s correlation coefficients measured the correlation of Whole Health domain scores with disease activity and PROMIS measures. Correlations were classified as strong ( >0.5), moderate (0.3-0.5), weak (0.1-0.3), or absent (< 0.1).High Type 1 SLE activity was defined as SLEDAI ≥6, clinical SLEDAI ≥4, Type 1 PGA ≥1, or active nephritis. High Type 2 SLE activity was defined as PSD ≥8 or Type 2 PGA ≥1. Among patients with ≥3 visits in the registry, Type 2 SLE patterns were classified as:No Type 2 SLEIntermittent Type 2 SLE: Type 2 SLE activity at ≤2 visits and Type 1 SLE activity at ≥1 visitPersistent Type 2 SLE: Type 2 SLE activity at 3 visits and Type 1 SLE activity at < 3 visits, or Type 2 SLE activity at ≥2 visits and Type 1 SLE activity at 0 visitsDifferences in median Whole Health Assessment scores across Type 2 pattern groups were compared using the Kruskal-Wallis test.

Results: We included 295 patients with SLE (mean age 44 years, 92% female, 60% Black, 33% White). Strong correlations were observed between Personal & Professional Goals with the SSS (r=-0.54) and FACIT Fatigue score (r=0.61; Table 2). Type 2 SLE activity measures were moderately correlated with Movement & Exercise, Rest, Purpose & Meaning in Life, Personal & Professional Goals, Stress, and Relationships. Weak correlations were found between Type 1 PGA and Purpose & Meaning in Life (r=-0.23) and Personal & Professional Goals (r=-0.23). Among 194 patients with ≥3 visits, patients with Persistent Type 2 SLE had worse scores across several Whole Health domains (Figure 1). When asked to indicate the areas of self-care most important to them, all groups selected “Rest” as the top domain (67-79%), followed by Movement & Exercise (42-51%), Nutrition (35-47%), and Purpose & Meaning in Life (39-40%).

Conclusion: Significant correlations were observed between Whole Health domains and Type 2 SLE activity measures, with scores decreasing as Type 2 SLE activity worsened. These findings helped support our development of a curriculum for a ’Whole Health’ program aimed at improving self-care and quality of life for patients with SLE through education, peer support, and goal setting outside of the clinical setting. Incorporating these insights into routine care can help address what matters most to patients.

Supporting image 1Table 1. The Whole Health Self-Assessment completed by patients with SLE.

Supporting image 2Table 2. Correlation of Whole Health Assessment Domains with Type 1 & 2 SLE Measures.

Supporting image 3Figure 1. Differences in Median Whole Health Domain Scores by Type 2 SLE Pattern.


Disclosures: A. Eudy: Aurinia, 2, GlaxoSmithKlein(GSK), 5, Immunovant, 5; M. Clowse: None; D. Burshell: Immunovant, 5; C. Drake: ZealCare, 12,, 10; T. Somers: None; D. Pisetsky: Bristol-Myers Squibb(BMS), 1, GlaxoSmithKlein(GSK), 2, Immunovant, 2, 5; R. Sadun: The Expert Institute, 12,; R. Snyderman: DNAnexus, 4, Heartland Whole Health Institute, 4, iRhythm Technologies, 4, OrthoTheapeutics, Inc., 1, ZealCare, 4; K. Sun: Aurinia, 2; L. Criscione-Schreiber: UCB, 5; M. Maheswaranathan: AstraZeneca, 2, UCB, 2; N. Harris: None; J. Doss: None; J. Rogers: AstraZeneca, 1, 1, Aurinia, 2, 5, Exagen, 5, Immunovant, 2, 5.

To cite this abstract in AMA style:

Eudy A, Clowse M, Burshell D, Drake C, Somers T, Pisetsky D, Sadun R, Snyderman R, Sun K, Criscione-Schreiber L, Maheswaranathan M, Harris N, Doss J, Rogers J. Assessing Whole Health Needs in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/assessing-whole-health-needs-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-whole-health-needs-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology